rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2002-10-23
|
pubmed:abstractText |
Prostaglandin E1 (PGE-1) is a potent vasodilative agent which has been used to bridge patients with chronic heart failure listed for heart transplantation (HTX). In various experimental settings PGE-1 appears to stimulate angiogenesis by inducing vascular endothelial growth factor expression. This observational clinical study sought to investigate the angiogenic effects of PGE-1 in the failing human heart.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alprostadil,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/HIF1A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxia-Inducible Factor 1,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxia-Inducible Factor 1, alpha...,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0008-6363
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
214-24
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12393092-Adult,
pubmed-meshheading:12393092-Aged,
pubmed-meshheading:12393092-Alprostadil,
pubmed-meshheading:12393092-Antigens, CD34,
pubmed-meshheading:12393092-Cell Culture Techniques,
pubmed-meshheading:12393092-Coronary Vessels,
pubmed-meshheading:12393092-DNA-Binding Proteins,
pubmed-meshheading:12393092-Endothelial Growth Factors,
pubmed-meshheading:12393092-Female,
pubmed-meshheading:12393092-Humans,
pubmed-meshheading:12393092-Hypoxia-Inducible Factor 1,
pubmed-meshheading:12393092-Hypoxia-Inducible Factor 1, alpha Subunit,
pubmed-meshheading:12393092-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:12393092-Ki-67 Antigen,
pubmed-meshheading:12393092-Lymphokines,
pubmed-meshheading:12393092-Male,
pubmed-meshheading:12393092-Middle Aged,
pubmed-meshheading:12393092-Muscle, Smooth, Vascular,
pubmed-meshheading:12393092-Myocardial Ischemia,
pubmed-meshheading:12393092-Neovascularization, Pathologic,
pubmed-meshheading:12393092-Nuclear Proteins,
pubmed-meshheading:12393092-Transcription Factors,
pubmed-meshheading:12393092-Vascular Endothelial Growth Factor A,
pubmed-meshheading:12393092-Vascular Endothelial Growth Factors,
pubmed-meshheading:12393092-von Willebrand Factor
|
pubmed:year |
2002
|
pubmed:articleTitle |
Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease.
|
pubmed:affiliation |
Department of Cardiology, University of Vienna, Vienna, Austria. mohammad.mehrabi@univie.ac.at
|
pubmed:publicationType |
Journal Article
|